{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "2425793",
  "DateCompleted": {
    "Year": "1986",
    "Month": "07",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "10",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0004-993X",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "2",
        "PubDate": {
          "Year": "1986",
          "Month": "May"
        }
      },
      "Title": "Australian paediatric journal",
      "ISOAbbreviation": "Aust Paediatr J"
    },
    "ArticleTitle": "New modalities in antiviral therapy.",
    "Pagination": {
      "StartPage": "87",
      "EndPage": "89",
      "MedlinePgn": "87-9"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cunningham",
        "ForeName": "A L",
        "Initials": "AL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Australia",
    "MedlineTA": "Aust Paediatr J",
    "NlmUniqueID": "15420340R",
    "ISSNLinking": "0004-993X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "49717AWG6K",
      "NameOfSubstance": "Ribavirin"
    },
    {
      "RegistryNumber": "9008-11-1",
      "NameOfSubstance": "Interferons"
    },
    {
      "RegistryNumber": "BF4C9Z1J53",
      "NameOfSubstance": "Amantadine"
    },
    {
      "RegistryNumber": "X4HES1O11F",
      "NameOfSubstance": "Acyclovir"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Acyclovir"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Amantadine"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Herpesviridae Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Interferons"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Respiratory Tract Infections"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Respirovirus Infections"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ribavirin"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Virus Diseases"
    }
  ]
}